Saturday, October 3, 2026

CBOE Bearish Momentum With A 34% Drop In The Last 10 Sessions

ViaNews Editorial Team

August 16, 2024

CBOE Bearish Momentum With A 34% Drop In The Last 10 Sessions

(VIANEWS) - CBOE (VIX) has been up by 34.67% for the last 10 sessions. At 04:08 EST on Friday, 16 August, CBOE (VIX) is $15.28.

Regarding CBOE's yearly highs and lows, it's 0.26% up from its 52-week low and 56.41% down from its 52-week high.

Volatility

CBOE's last week, last month's, and last quarter's current intraday variation average was a negative 7.71%, a negative 1.93%, and a positive 5.78%, respectively.

CBOE's highest amplitude of average volatility was 8.55% (last week), 11.25% (last month), and 5.78% (last quarter), respectively.

Index Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, CBOE's is considered to be overbought (>=80).

News about

  • According to Zacks on Wednesday, 14 August, "Invesco S&P 500 Pure Growth ETF (RPG Quick QuoteRPG - Free Report) - Zacks Rank #2 (Buy); P/E: 10.63X", "The underlying S&P 500 Pure Growth Index measures the performance of securities that exhibit strong growth characteristics in the S&P 500 Index. "
  • According to Zacks on Wednesday, 14 August, "The sector has done very well this year already, with the S&P 500 Select Sector SPDR (XLU) advancing 16.7% year to date as of Jul 31, 2024."
  • According to FXStreet on Wednesday, 14 August, "The current Elliott Wave count suggests a bullish setup, specifically wave (iii) of iii) of 3 of (1) of 5) for both the S&P 500 and NASDAQ 100. "
  • According to Zacks on Wednesday, 14 August, "Currently, we see the Dow +10 points, the S&P 500 +15 and the Nasdaq +45 points. "
  • According to The Guardian on Wednesday, 14 August, "The S&P 500 ended up rising 2.3% in one day, its biggest jump since November 2022."

More news about CBOE (VIX).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI-Driven Drug Development Meets Biotech Deal-Making and Regulatory Catalysts
AI-designed therapeutics (Insilico's rentosertib showing biological-age reductions) are moving into the clinical mainstream. Large-cap biotech is simultaneously reallocating capital through M&A (Lilly–Merida, $2.9B) and government funding (BARDA–Basilea), while trial failures (ziltivekimab, a 9.4% Novo Nordisk share drop) and upcoming FDA catalysts (the ivonescimab PDUFA on 2026-11-14) drive volatility. The wider AI regulatory and legal climate (Tesla Cybercab probe, xAI's Minnesota loss, OpenAI suits) is tightening, though QAIAx's micro-cap trial claims are speculative and weakly connected.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,327 source documents archived
Query this data → isubstrate.com